UCB has a deep-rooted legacy in epilepsy care, including support for those with rare and severe forms of epilepsy, such as Lennox-Gastaut syndrome (LGS). This #EpilepsyAwarenessMonth, we highlight our commitment to improving outcomes for individuals living with epilepsy. By addressing their unique challenges, we strive to enhance their quality of life through innovative solutions and comprehensive support. #EpilepsyAwareness
About us
UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients. Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives. UCB – The Facts With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs. A few other reasons that make UCB an amazing place to work: - Promising pipeline that includes several novel molecules; - 2023 Key Financials: € 5.3 billion global revenue Specialties: Neurology, Immunology
- Website
-
http://www.ucb.com
External link for UCB
- Industry
- Pharmaceutical Manufacturing
- Company size
- 5,001-10,000 employees
- Headquarters
- Brussels
- Type
- Privately Held
- Founded
- 1928
- Specialties
- Neurology, Immunology, and Healthcare Innovation Beyond Medicine
Locations
Employees at UCB
Updates
-
Lennox-Gastaut syndrome (LGS) impacts every aspect of family life, from managing unpredictable seizures to navigating behavioural challenges. At UCB, we are committed to advancing treatments and working towards a brighter future for all those affected by LGS. #LGSAwarenessDay. https://lnkd.in/e-ZHvJkC
-
At UCB, we are committed to improving care for people living with Lennox-Gastaut syndrome (LGS). On #LGSAwarenessDay help us raise awareness of the prevalence and burden of this rare form of #epilepsy. Together, we can make a real difference to the lives of patients. https://lnkd.in/e-ZHvJkC
-
Ahead of #LGSAwarenessDay, discover Dr. Tracy Dixon-Salazar’s journey as a carer for her daughter Savannah and how UCB is supporting the Lennox-Gastaut Syndrome (LGS) Foundation to drive change for the LGS community and those living with #epilepsy. https://lnkd.in/eaHEwqgM
-
Reflecting on #WorldPsoriasisDay, we honor the resilience of the psoriatic disease community and recognize the daily challenges faced by those living with #psoriasis and #psoriaticarthritis. Our aim at UCB to advance Immunology solutions is driven by dedicated leaders like Jeffrey Stark, MD, U.S. Head of Medical Immunology at UCB, who is committed to advancing science that can make a difference for people living with psoriatic disease. We're proud Dr. Stark has been appointed to the National Psoriasis Foundation's Scientific Advisory Committee, where his deep commitment to the community and extensive knowledge will help further the Foundation's mission.
-
🌍 World Psoriasis Day 2024: Caroline’s story. This World Psoriasis Day, hear from Caroline as she shares the reality of living with psoriasis and psoriatic arthritis and the impact it can have on families. We’re privileged to share voices like Caroline’s, as they provide valuable insight into the importance of understanding the wide-reaching impact of chronic conditions such as psoriasis and psoriatic arthritis. On this year’s #worldpsoriasisday, we are proud to join IFPA to showcase the theme of “Family” and amplify the voices of those living with psoriasis and psoriatic arthritis. Read more about Caroline’s experience on UCB.com💜 https://lnkd.in/eJHMrxZQ
-
🌍 Celebrating families on World Psoriasis Day. Tuesday 29 October marks World Psoriasis Day. This year’s theme of “Family” aims to highlight the impact that psoriasis and psoriatic arthritis can have on those living with these conditions, as well as their families💜. Join us next week on #worldpsoriasisday to unite with the global community as we support all those living with psoriasis and psoriatic arthritis. Together, we can make a difference 💪.
-
While World Osteoporosis Day 2024 has passed, UCB’s commitment to bone health continues. We encourage you to Question Fractures More and stay active and independent as you get older. Learn more at https://lnkd.in/e5iMf95T #WOD2024 #BoneHealth #MythBusters #Health #Fractures #WOD
-
At UCB, we’re committed to challenging the way we think about fractures. It’s time to connect the dots between fractures and osteoporosis, and we’re encouraging everyone to Question Fractures More to help identify osteoporosis and prevent future fractures. Learn more at https://lnkd.in/e5iMf95T #DidYouKnow #Osteoporosis #Fracture #FactOrFiction #Facts #WOD
-
Going the extra mile is second nature here. Whether it's creating new solutions for people living with severe diseases or finding ways to better support our colleagues and communities, we're always thinking beyond the task at hand. Every challenge is an opportunity to innovate, grow, and make a lasting impact. UCB is where you're encouraged to push forward, try new approaches, and make meaningful contributions—not just for today but for the future. Ready to see where your ideas can take you? Discover how you can be part of our team. #MakeYourMarkForPatients #TeamUCB #PharmaJobs Learn more at UCB Careers: https://brnw.ch/21wNZHy